Brief: BioInvent Q4 Sales SEK 15.3 Million

BioInvent International AB

22/02/2024 08:24

Feb 22 (Reuters) - BioInvent Q4 adjusted free cash flow SEK -72.4 million.
* Q4 adjusted EPS SEK -1.48
* Q4 net income SEK -97.2 million
* Q4 sales SEK 15.3 million